Sleep, circadian rhythms, and the pathogenesis of Alzheimer Disease

Experimental and Molecular Medicine

Volumn 47, Issue 3, 2015, Pages

  Musiek, Erik S ^a   Xiong, David D ^a   Holtzman, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ANIMAL; CIRCADIAN RHYTHM; DISEASE MODEL; HUMAN; MOUSE; SLEEP;

ALZHEIMER DISEASE; ANIMALS; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; HUMANS; MICE; SLEEP;

EID: 84989315906     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/EMM.2014.121     Document Type: Article

References (92)

1. Ju YE, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology–a bidirectional relationship. Nat Rev Neurol 2014; 10: 115–119.
2. Peter-Derex L, Yammine P, Bastuji H, Croisile B. Sleep and Alzheimer's disease. Sleep Med Rev 2015; 19C: 29–38.
3. Hatfield CF, Herbert J, van Someren EJ, Hodges JR, Hastings MH. Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain 2004; 127: 1061–1074.
4. Prinz PN, Peskind ER, Vitaliano PP, Raskind MA, Eisdorfer C, Zemcuznikov N et al. Changes in the sleep and waking EEGs of nondemented and demented elderly subjects. J Am Geriatr Soc 1982; 30: 86–93.
5. Petit D, Gagnon JF, Fantini ML, Ferini-Strambi L, Montplaisir J. Sleep and quantitative EEG in neurodegenerative disorders. J Psychosom Res 2004; 56: 487–496.
6. Martin PR, Loewenstein RJ, Kaye WH, Ebert MH, Weingartner H, Gillin JC. Sleep EEG in Korsakoff's psychosis and Alzheimer's disease. Neurology 1986; 36: 411–414.
7. Loewenstein RJ, Weingartner H, Gillin JC, Kaye W, Ebert M, Mendelson WB. Disturbances of sleep and cognitive functioning in patients with dementia. Neurobiol Aging 1982; 3: 371–377.
8. Roh JH, Huang Y, Bero AW, Kasten T, Stewart FR, Bateman RJ et al. Disruption of the sleep-wake cycle and diurnal fluctuation of beta-amyloid in mice with Alzheimer's disease pathology. Sci Transl Med 2012; 4: 150ra122.
9. Duncan MJ, Smith JT, Franklin KM, Beckett TL, Murphy MP, St Clair DK et al. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease. Exp Neurol 2012; 236: 249–258.
10. Sterniczuk R, Dyck RH, Laferla FM, Antle MC. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes. Brain Res 2010; 1348: 139–148.
11. Jyoti A, Plano A, Riedel G, Platt B. EEG, activity, and sleep architecture in a transgenic AbetaPPswe/PSEN1A246E Alzheimer's disease mouse. JAlz-heimers Dis 2010; 22: 873–887.
12. Platt B, Drever B, Koss D, Stoppelkamp S, Jyoti A, Plano A et al. Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1. PLoS ONE 2011; 6: e27068.
13. Wisor JP, Edgar DM, Yesavage J, Ryan HS, McCormick CM, Lapustea N et al. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission. Neuroscience 2005; 131: 375–385.
14. Zhang B, Veasey SC, Wood MA, Leng LZ, Kaminski C, Leight S et al. Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer's disease with injury to pedunculopontine cholinergic neurons. Am J Pathol 2005; 167: 1361–1369.
15. Hahn EA, Wang HX, Andel R, Fratiglioni L. A change in sleep pattern may predict Alzheimer Disease. Am J Geriatr Psychiatry 2014; 22: 1262–1271.
16. Sterniczuk R, Theou O, Rusak B, Rockwood K. Sleep disturbance is associated with incident dementia and mortality. Curr Alzheimer Res 2013; 10: 767–775.
17. Potvin O, Lorrain D, Forget H, Dube M, Grenier S, Preville M et al. Sleep quality and 1-year incident cognitive impairment in community-dwelling older adults. Sleep 2012; 35: 491–499.
18. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003; 26: 342–392.
19. Marino M, Li Y, Rueschman MN, Winkelman JW, Ellenbogen JM, Solet JM et al. Measuring sleep: accuracy, sensitivity, and specificity of wrist actigraphy compared to polysomnography. Sleep 2013; 36: 1747–1755.
20. Lim AS, Yu L, Costa MD, Leurgans SE, Buchman AS, Bennett DA et al. Increased fragmentation of rest-activity patterns is associated with a characteristic pattern of cognitive impairment in older individuals. Sleep 2012; 35: 633–640B.
21. Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA. Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons. Sleep 2013; 36: 1027–1032.
22. Lim AS, Yu L, Kowgier M, Schneider JA, Buchman AS, Bennett DA. Modification of the relationship of the apolipoprotein E epsilon4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol 2013; 70: 1544–1551.
23. Ju YE, McLeland JS, Toedebusch CD, Xiong C, Fagan AM, Duntley SP et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol 2013; 70: 587–593.
24. Spira AP, Gamaldo AA, An Y, Wu MN, Simonsick EM, Bilgel M et al. Self-reported sleep and beta-amyloid deposition in community-dwelling older adults. JAMA Neurol 2013; 70: 1537–1543.
25. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009; 326: 1005–1007.
26. Huang Y, Potter R, Sigurdson W, Santacruz A, Shih S, Ju YE et al. Effects of age and amyloid deposition on Abeta dynamics in the human central nervous system. Arch Neurol 2012; 69: 51–58.
27. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T et al. APP processing and synaptic function. Neuron 2003; 37: 925–937.
28. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 2005; 48: 913–922.
29. Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME et al. Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat Neurosci 2011; 14: 750–756.
30. Nir Y, Staba RJ, Andrillon T, Vyazovskiy VV, Cirelli C, Fried I et al. Regional slow waves and spindles in human sleep. Neuron 2011; 70: 153–169.
31. Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M et al. Sleep drives metabolite clearance from the adult brain. Science 2013; 342: 373–377.
32. Rothman SM, Herdener N, Frankola KA, Mughal MR, Mattson MP. Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Abeta and pTau in a mouse model of Alzheimer's disease. Brain Res 2013; 1529: 200–208.
33. Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. JNeurosci2006; 26: 9047–9056.
34. Kang JE, Cirrito JR, Dong H, Csernansky JG, Holtzman DM. Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proc Natl Acad Sci USA 2007; 104: 10673–10678.
35. Dong H, Yuede CM, Yoo HS, Martin MV, Deal C, Mace AG et al. Corticosterone and related receptor expression are associated with increased beta-amyloid plaques in isolated Tg2576 mice. Neuroscience 2008; 155: 154–163.
36. Rothman SM, Herdener N, Camandola S, Texel SJ, Mughal MR, Cong WN et al. 3xTgAD mice exhibit altered behavior and elevated Abeta after chronic mild social stress. Neurobiol Aging 2012; 33: 830 e831-812.
37. Ooms S, Overeem S, Besse K, Rikkert MO, Verbeek M, Claassen JA. Effect of 1 night of total sleep deprivation on cerebrospinal fluid beta-Amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA Neurol 2014; 71: 971–977.
38. Di Meco A, Joshi YB, Pratico D. Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles. Neurobiol Aging 2014; 35: 1813–1820.
39. Benedict C, Cedernaes J, Giedraitis V, Nilsson EK, Hogenkamp PS, Vagesjo E et al. Acute sleep deprivation increases serum levels of neuron-specific enolase (NSE) and S100 calcium binding protein B (S-100B) in healthy young men. Sleep 2014; 37: 195–198.
40. Zhang J, Zhu Y, Zhan G, Fenik P, Panossian L, Wang MM et al. Extended wakefulness: compromised metabolics in and degeneration of locus ceruleus neurons. JNeurosci2014; 34: 4418–4431.
41. Naidoo N, Ferber M, Master M, Zhu Y, Pack AI. Aging impairs the unfolded protein response to sleep deprivation and leads to proapoptotic signaling. JNeurosci2008; 28: 6539–6548.
42. Naidoo N, Giang W, Galante RJ, Pack AI. Sleep deprivation induces the unfolded protein response in mouse cerebral cortex. JNeurochem2005; 92: 1150–1157.
43. Yan P, Bero AW, Cirrito JR, Xiao Q, Hu X, Wang Y et al. Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice. JNeurosci 2009; 29: 10706–10714.
44. Weaver DR. The suprachiasmatic nucleus: a 25-year retrospective. JBiol Rhythms 1998; 13: 100–112.
45. Mohawk JA, Green CB, Takahashi JS. Central and peripheral circadian clocks in mammals. Annu Rev Neurosci 2012; 35: 445–462.
46. Abe M, Herzog ED, Yamazaki S, Straume M, Tei H, Sakaki Y et al. Circadian rhythms in isolated brain regions. J Neurosci 2002; 22: 350–356.
47. Marpegan L, Swanstrom AE, Chung K, Simon T, Haydon PG, Khan SK et al. Circadian regulation of ATP release in astrocytes. JNeurosci2011; 31: 8342–8350.
48. Ptitsyn AA, Zvonic S, Conrad SA, Scott LK, Mynatt RL, Gimble JM. Circadian clocks are resounding in peripheral tissues. PLoS Comput Biol 2006; 2: e16.
49. Husse J, Leliavski A, Tsang AH, Oster H, Eichele G. The light-dark cycle controls peripheral rhythmicity in mice with a genetically ablated supra-chiasmatic nucleus clock. FASEB J 2014; 28: 4950–4960.
50. Kondratov RV, Antoch MP. The clock proteins, aging, and tumorigenesis. Cold Spring Harb Symp Quant Biol 2007; 72: 477–482.
51. Anea CB, Zhang M, Stepp DW, Simkins GB, Reed G, Fulton DJ et al. Vascular disease in mice with a dysfunctional circadian clock. Circulation 2009; 119: 1510–1517.
52. Bass J, Takahashi JS. Circadian integration of metabolism and energetics. Science 2010; 330: 1349–1354.
53. Evans JA, Davidson AJ. Health consequences of circadian disruption in humans and animal models. Prog Mol Biol Transl Sci 2013; 119: 283–323.
54. Bunger MK, Wilsbacher LD, Moran SM, Clendenin C, Radcliffe LA, Hogenesch JB et al. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 2000; 103: 1009–1017.
55. Laposky A, Easton A, Dugovic C, Walisser J, Bradfield C, Turek F. Deletion of the mammalian circadian clock gene BMAL1/Mop3 alters baseline sleep architecture and the response to sleep deprivation. Sleep 2005; 28: 395–409.
56. Mongrain V, La Spada F, Curie T, Franken P. Sleep loss reduces the DNA-binding of BMAL1, CLOCK, and NPAS2 to specific clock genes in the mouse cerebral cortex. PLoS ONE 2011; 6: e26622.
57. Chang HC, Guarente L. SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell 2013; 153: 1448–1460.
58. Witting W, Kwa IH, Eikelenboom P, Mirmiran M, Swaab DF. Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol Psychiatry 1990; 27: 563–572.
59. Coogan AN, Schutova B, Husung S, Furczyk K, Baune BT, Kropp P et al. The circadian system in Alzheimer's disease: disturbances, mechanisms, and opportunities. Biol Psychiatry 2013; 74: 333–339.
60. Hu K, Van Someren EJ, Shea SA, Scheer FA. Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: involvement of the circadian pacemaker. Proc Natl Acad Sci USA 2009; 106: 2490–2494.
61. Wu YH, Fischer DF, Kalsbeek A, Garidou-Boof ML, van der Vliet J, van Heijningen C et al. Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the "master clock". FASEB J 2006; 20: 1874–1876.
62. Skene DJ, Swaab DF. Melatonin rhythmicity: effect of age and Alzheimer's disease. Exp Gerontol 2003; 38: 199–206.
63. Chen KF, Possidente B, Lomas DA, Crowther DC. The central molecular clock is robust in the face of behavioural arrhythmia in a Drosophila model of Alzheimer's disease. Dis Model Mech 2014; 7: 445–458.
64. Long DM, Blake MR, Dutta S, Holbrook SD, Kotwica-Rolinska J, Kretzsch-mar D et al. Relationships between the Circadian system and Alzheimer's disease-like symptoms in Drosophila. PLoS ONE 2014; 9: e106068.
65. Harper DG, Stopa EG, Kuo-Leblanc V, McKee AC, Asayama K, Volicer L et al. Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia. Brain 2008; 131: 1609–1617.
66. Swaab DF, Fliers E, Partiman TS. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res 1985; 342: 37–44.
67. Zhou JN, Hofman MA, Swaab DF. VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol Aging 1995; 16: 571–576.
68. Farajnia S, Michel S, Deboer T, Vanderleest HT, Houben T, Rohling JH et al. Evidence for neuronal desynchrony in the aged suprachiasmatic nucleus clock. JNeurosci2012; 32: 5891–5899.
69. Kunieda T, Minamino T, Katsuno T, Tateno K, Nishi J, Miyauchi H et al. Cellular senescence impairs circadian expression of clock genes in vitro and in vivo. Circ Res 2006; 98: 532–539.
70. Wyse CA, Coogan AN. Impact of aging on diurnal expression patterns of CLOCK and BMAL1 in the mouse brain. Brain Res 2010; 1337: 21–31.
71. Tranah GJ, Blackwell T, Stone KL, Ancoli-Israel S, Paudel ML, Ensrud KE et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol 2011; 70: 722–732.
72. Chen HF, Huang CQ, You C, Wang ZR, Si-qing H. Polymorphism of CLOCK gene rs 4580704 C4G is associated with susceptibility of Alzheimer's disease in a Chinese population. Arch Med Res 2013; 44: 203–207.
73. Chen Q, Huang CQ, Hu XY, Li SB, Zhang XM. Functional CLOCK gene rs1554483 G/C polymorphism is associated with susceptibility to Alzheimer's disease in the Chinese population. J Int Med Res 2013; 41: 340–346.
74. Yang YK, Peng XD, Li YH, Wang ZR, Chang-quan H, Hui W et al. The polymorphism of CLOCK gene 3111 T/C C4T is associated with susceptibility of Alzheimer disease in Chinese population. J Investig Med 2013; 61: 1084–1087.
75. Musiek ES, Lim MM, Yang G, Bauer AQ, Qi L, Lee Y et al. Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. JClin Invest 2013; 123: 5389–5400.
76. Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. JPinealRes2011; 51: 1–16.
77. Rosales-Corral SA, Acuna-Castroviejo D, Coto-Montes A, Boga JA, Manche-ster LC, Fuentes-Broto L et al. Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin. J Pineal Res 2012; 52: 167–202.
78. Zhou JN, Liu RY, Kamphorst W, Hofman MA, Swaab DF. Early neuro-pathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. JPinealRes2003; 35: 125–130.
79. Furio AM, Brusco LI, Cardinali DP. Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study. JPinealRes2007; 43: 404–409.
80. Quinn J, Kulhanek D, Nowlin J, Jones R, Pratico D, Rokach J et al. Chronic melatonin therapy fails to alter amyloid burden or oxidative damage in old Tg2576 mice: implications for clinical trials. Brain Res 2005; 1037: 209–213.
81. Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ et al. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. JPinealRes2009; 47: 82–96.
82. Feng Z, Qin C, Chang Y, Zhang JT. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease. Free Radic Biol Med 2006; 40: 101–109.
83. Garcia-Mesa Y, Gimenez-Llort L, Lopez LC, Venegas C, Cristofol R, Escames G et al. Melatonin plus physical exercise are highly neuroprotec-tive in the 3xTg-AD mouse. Neurobiol Aging 2012; 33: 1124 e1113-1129.
84. Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A et al. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 2005; 9: 41–50.
85. Gehrman PR, Connor DJ, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am J Geriatr Psychiatry 2009; 17: 166–169.
86. Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M et al. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 2003; 26: 893–901.
87. Van Someren EJ, Kessler A, Mirmiran M, Swaab DF. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry 1997; 41: 955–963.
88. Dowling GA, Burr RL, Van Someren EJ, Hubbard EM, Luxenberg JS, Mastick J et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J Am Geriatr Soc 2008; 56: 239–246.
89. Riemersma-van der Lek RF, Swaab DF, Twisk J, Hol EM, Hoogendijk WJ, Van Someren EJ. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA 2008; 299: 2642–2655.
90. Hirota T, Lee JW, Lewis WG, Zhang EE, Breton G, Liu X et al. High-throughput chemical screen identifies a novel potent modulator of cellular circadian rhythms and reveals CKIalpha as a clock regulatory kinase. PLoS Biol 2010; 8: e1000559.
91. Chen Z, Yoo SH, Park YS, Kim KH, Wei S, Buhr E et al. Identification of diverse modulators of central and peripheral circadian clocks by high-throughput chemical screening. Proc Natl Acad Sci USA 2012; 109: 101–106.
92. Solt LA, Wang Y, Banerjee S, Hughes T, Kojetin DJ, Lundasen T et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature 2012; 485: 62–68.